Related Experiment Videos
Treating hypertension in the elderly: protagonist viewpoint
1State University of New York Downstate Medical College, USA. mweber@downstate.edu
Insights
Treating systolic hypertension in older adults significantly reduces cardiovascular events like stroke and heart failure. Evidence supports treatment even for less severe hypertension stages, potentially benefiting dementia risk.
Area of Science:
- Gerontology
- Cardiology
- Public Health
Background:
- Cardiovascular disease is a leading cause of death in the U.S.
- Aging increases cardiovascular event risk, largely due to hypertension and diabetes.
- Systolic hypertension, common in older adults, is a major risk factor for stroke and heart failure.
Purpose of the Study:
- To evaluate the benefits of treating systolic hypertension in the elderly.
- To assess the extrapolation of treatment benefits to less severe hypertension stages.
- To review evidence for stroke and dementia prevention in older hypertensive patients.
Main Methods:
- Analysis of clinical trial evidence on hypertension treatment in older adults.
- Extrapolation of treatment guidelines from Stage 2 to Stage 1 systolic hypertension.
- Review of studies focusing on octogenarians and treatment outcomes.
Main Results:
- Treating elderly patients with hypertension significantly decreases cardiovascular events.
- Evidence supports treating Stage 1 systolic hypertension by extrapolating from Stage 2 findings.
- Strokes are demonstrably preventable in octogenarians through hypertension treatment.
Conclusions:
- Hypertension treatment is crucial for reducing cardiovascular risk in the elderly.
- Benefits of treating systolic hypertension can be extrapolated to less severe cases.
- Hypertension management in older adults may reduce dementia incidence, requiring further confirmation.
Abstract:
Cardiovascular disease is the main cause of serious illness and death in the United States. Increasing age is a strong predictor of cardiovascular events, driven largely by such major conditions as hypertension and diabetes mellitus. Systolic hypertension probably reflects progressive stiffening of large and small arteries; close to 90% of all Americans will have this diagnosis by their 80s. Regardless of age, systolic hypertension is a powerful risk factor for stroke, heart failure, and other cardiovascular outcomes. Treating hypertension in the elderly sharply decreases the probability of these events. Clinical trial evidence does not include patients with stage 1 systolic hypertension (140-159 mm Hg), although the results in stage 2 are so convincing that it is very reasonable (as concluded by national guidelines committees) to extrapolate benefits and recommend treatment to patients in the less-severe group. Whereas evidence of treatment benefits in patients aged 80 years and older is limited, sufficient octogenarians have been studied to confidently assert that strokes, at least, can be prevented. Another potentially important benefit that is yet to be fully confirmed is that treating hypertension in older people may also reduce the incidence of dementia.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure